Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet

Name: Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet
Brand: CARE FORMULATION LABS PRIVATE LIMITED
Price: 68.0 INR
Availability: InStock

Price 68.0 INR/ Strip

Get a Price/Quote

MOQ : 100 Strips

Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet Specification

Pacakaging (Quantity Per Box)
10x10 tablet

Salt Composition
Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet

Dosage Form
Tablet

Ingredients
Azathioprine (25 mg).

Physical Form
Tablets

Dosage Guidelines
Use as directed by a healthcare professional

Storage Instructions
room temperature

About Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet

Description

Each Film Coated Extended Release tablet Contains Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg)

Doses

As Directed by physician

Indication

Valproate (VPA) and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy andbipolar disorder and preventmigraine headaches.
They are useful for theprevention of seizures in those with absence seizures, partial seizures, and generalized seizures.

Comprehensive Therapeutic Support

This tablet offers a synergy of sodium valproate and azathioprine, providing an effective solution for individuals requiring both anticonvulsant and immunosuppressive therapy. The extended release formulation ensures sustained plasma levels, minimizing dosing frequency and enhancing patient compliance. Suitable for professional healthcare use.

Instructions for Safe Usage

The tablets are to be used strictly as directed by a healthcare professional. Adherence to recommended dosage and administration guidelines greatly reduces the risk of adverse effects. Store the tablets at room temperature and ensure they are kept out of reach of children. Regular follow-up and monitoring are important throughout the course of therapy.

FAQ's of Sodium Valproate IP 200 mg Valproic Acid IP 87 mg (Both together Correspond Sodium Valproate 300 mg) Extended Release tablet:

Q: How should I take the Sodium Valproate and Valproic Acid Extended Release tablet with Azathioprine?

A: Take the tablet exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, adhering to the dosage and schedule instructed by your doctor to ensure optimal benefit and minimize risks.

Q: What are the main ingredients in these tablets?

A: Each tablet contains Sodium Valproate IP 200 mg, Valproic Acid IP 87 mg (equivalent to 300 mg Sodium Valproate), and 25 mg Azathioprine as the active components.

Q: When is this combination tablet typically used?

A: This medication is generally used under medical supervision to manage certain neurological disorders or autoimmune conditions that require both anticonvulsant and immunosuppressive therapy. Only initiate treatment on your physician's advice.

Q: Where should I store these tablets?

A: Store the tablets at room temperature, away from direct sunlight and moisture. Always keep them in their original packaging until use to maintain their effectiveness.

Q: What is the process for obtaining these tablets in India?

A: You can obtain these tablets through authorized dealers, distributors, retailers, and wholesalers across India. Please ensure you present a valid prescription to purchase this medication.

Q: What are the potential benefits of using this formulation?

A: The extended release and combined formulation can provide steady therapeutic action, greater convenience with less frequent dosing, and simultaneous management of applicable neurological and autoimmune conditions.

Tell us about your requirement